» Articles » PMID: 38703308

High Intensity Focused Ultrasound (20 MHz) and Cryotherapy As Therapeutic Options for Granuloma Annulare and Other Inflammatory Skin Conditions

Overview
Date 2024 May 4
PMID 38703308
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: In dermatology, inflammatory skin conditions impose a substantial burden worldwide, with existing therapies showing limited efficacy and side effects. This report aims to compare a novel immunological activation induced by hyperthermic 20 MHz high intensity focused ultrasound (HIFU) with conventional cryotherapy. The bioeffects from the two methods are initially investigated by numerical models, and subsequently compared to clinical observations after treatment of a patient with the inflammatory disease granuloma annulare (GA).

Methods: Clinical responses to moderate energy HIFU and cryotherapy were analysed using numerical models. HIFU-induced pressure and heat transfer were calculated, and a three-layer finite element model simulated temperature distribution and necrotic volume in the skin. Model output was compared to 22 lesions treated with HIFU and 10 with cryotherapy in a patient with GA.

Results: Cryotherapy produced a necrotic volume of 138.5 mm at - 92.7 °C. HIFU at 0.3-0.6 J/exposure and focal depths of 0.8 or 1.3 mm generated necrotic volumes up to only 15.99 mm at temperatures of 68.3-81.2 °C. HIFU achieved full or partial resolution in all treated areas, confirming its hyperthermic immunological activation effect, while cryotherapy also resolved lesions but led to scarring and dyspigmentation.

Conclusion: Hyperthermic immunological activation of 20 MHz HIFU shows promise for treating inflammatory skin conditions as exemplified by GA. Numerical models demonstrate minimal skin necrosis compared to cryotherapy. Suggested optimal HIFU parameters are 1.3 mm focal depth, 0.4-0.5 J/exposure, 1 mm spacing, and 1 mm margin. Further studies on GA and other inflammatory diseases are recommended.

Citing Articles

Case report: Sequential treatment strategy for advanced basal cell carcinoma in Gorlin-Goltz syndrome: integration of vismodegib, radiotherapy, surgery, and high-intensity focused ultrasound.

Calik J, Oslizlo M, Slocka-Romaniuk B, Elsaftawy A, Sauer N Front Oncol. 2024; 14:1428702.

PMID: 39091908 PMC: 11291366. DOI: 10.3389/fonc.2024.1428702.

References
1.
Calik J, Migdal M, Zawada T, Bove T . Treatment of Seborrheic Keratosis by High Frequency Focused Ultrasound - An Early Experience with 11 Consecutive Cases. Clin Cosmet Investig Dermatol. 2022; 15:145-156. PMC: 8808045. DOI: 10.2147/CCID.S348106. View

2.
Goss S, Frizzell L, Dunn F . Ultrasonic absorption and attenuation in mammalian tissues. Ultrasound Med Biol. 1979; 5(2):181-6. DOI: 10.1016/0301-5629(79)90086-3. View

3.
Mortazavi S, Mokhtari-Dizaji M . Numerical study of high-intensity focused ultrasound (HIFU) in fat reduction. Skin Res Technol. 2023; 29(1):e13280. PMC: 10155805. DOI: 10.1111/srt.13280. View

4.
Serup J, Bove T, Zawada T, Jessen A, Poli M . High-frequency (20 MHz) high-intensity focused ultrasound: New Treatment of actinic keratosis, basal cell carcinoma, and Kaposi sarcoma. An open-label exploratory study. Skin Res Technol. 2020; 26(6):824-831. PMC: 7754281. DOI: 10.1111/srt.12883. View

5.
Seyed Jafari S, Cazzaniga S, Bossart S, Feldmeyer L, Pelloni L, van Rhyn M . Efficacy Assessment of the High-Frequency High-Intensity Focused Ultrasound as a New Treatment for Actinic Keratosis. Dermatology. 2021; 238(4):662-667. DOI: 10.1159/000520536. View